Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Catalyst Pharmaceuticals Inc    CPRX

Delayed Quote. Delayed  - 08/30 10:00:00 pm
1.03 USD   -3.29%
08/09 Catalyst Pharmaceuticals Announces Second Quarter 2016 Financial ..
08/01 Catalyst Pharmaceuticals to Hold Second Quarter Financial Results..
07/13 WEDNESDAY 7/13 : Cprx, good
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
08/24/2016 08/25/2016 08/26/2016 08/29/2016 08/30/2016 Date
1.06(c) 1.08(c) 1.09(c) 1.065(c) 1.03 Last
3 386 977 950 836 732 504 610 188 473 209 Volume
+3.92% +1.89% +0.93% -2.29% -3.29% Change
More quotes
Financials ($)
Sales 2016 -
EBIT 2016 -21,8 M
Net income 2016 -21,1 M
Debt 2016 -
Yield 2016 -
Sales 2017 -
EBIT 2017 -26,2 M
Net income 2017 -26,1 M
Debt 2017 -
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017
Capi. / Sales2016 0
Capi. / Sales2017 0
Capitalization 88,3 M
More Financials
Company
Catalyst Pharmaceuticals, Inc. is a biopharmaceutical company.It focuses on development and commercialization of prescription drugs targeting rare (orphan) neuromuscular and neurological diseases, including Lambert-Eaton Myasthenic Syndrome (LEMS), infantile spasms, and Tourette's disorder.The... 
More about the company
Surperformance© ratings of Catalyst Pharmaceuticals I
Trading Rating : Investor Rating : -
More Ratings
Latest news on CATALYST PHARMACEUTICALS I
08/09 CATALYST PHARMACEUTICALS, INC. : Other Events, Financial Statements and Exhibits..
08/09 CATALYST PHARMACEUTICALS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CON..
08/09 Catalyst Pharmaceuticals Announces Second Quarter 2016 Financial Results and ..
08/01 Catalyst Pharmaceuticals to Hold Second Quarter Financial Results and Corpora..
07/13 WEDNESDAY 7/13 INSIDER BUYING REPORT : Cprx, good
06/24 CATALYST PHARMACEUTICALS, INC. : Change in Directors or Principal Officers, Fina..
06/14 CATALYST PHARMACEUTICALS : Announces Agreement with FDA on Confirmatory Phase 3 ..
06/13 CATALYST PHARMACEUTICALS, INC. : Other Events, Financial Statements and Exhibits..
06/13 Catalyst Pharmaceuticals Announces Agreement with FDA on Confirmatory Phase 3..
06/10 CATALYST PHARMACEUTICALS, INC. : Notice of Delisting or Failure to Satisfy a Con..
More news
Sector news : Bio Therapeutic Drugs
08/30DJNOVARTIS : FDA Approves Novartis's Biosimilar to Amgen's Enbrel
08/29DJSANOFI : Regeneron Announce Positive Trials for Cholesterol Drug
08/24DJAMGEN : FDA Rejects Amgen Hormonal-Imbalance Treatment
08/24DJAMGEN : FDA Rejects Amgen Hormonal-Imbalance Treatment
08/23DJDeal for Medivation Is the Latest In a Line of Similar Acquisitions -- WSJ
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
08/24 Midday Gainers / Losers
08/24 HEALTHCARE - TOP GAINERS / LOSERS AS : 00 am
08/10 Catalyst Pharmaceutical Partners' (CPRX) CEO Pat McEnany on Q2 2016 Results -..
08/09 Catalyst Pharmaceutical beats by $0.02
07/13 INSIDERINSIGHTS.COM DAILY ROUND UP 7 : US Geothermal, OPKO Health, Kingsway Fina..
Advertisement
Chart CATALYST PHARMACEUTICALS I
Duration : Period :
Catalyst Pharmaceuticals I Technical Analysis Chart | CPRX | US14888U1016 | 4-Traders
Full-screen chart
Technical analysis trends CATALYST PHARMACE...
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 4
Average target price 3,63 $
Spread / Average Target 240%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Patrick J. McEnany Chairman, President, CEO & Contact Person
Steven R. Miller Chief Operating & Scientific Officer
Alicia Grande Chief Financial Officer, Treasurer & VP
Gary Ingenito Chief Medical Officer
Philip H. Coelho Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
CATALYST PHARMACEUTICA..-56.53%88
AMGEN, INC.5.66%128 351
GILEAD SCIENCES, INC.-22.75%103 158
CELGENE CORPORATION-9.86%83 674
REGENERON PHARMACEUTIC..-26.43%42 053
VERTEX PHARMACEUTICALS..-22.96%24 020
More Results